share_log

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

ocugen 發佈 OCU410l 的初步數據;結果包括沒有與藥物相關的嚴重不良事件,病變生長減緩,視網膜組織保存,對低亮度視覺敏感度的功能視覺測量產生積極影響。
Benzinga ·  2024/11/19 20:08

Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity

Ocugen公佈了OCU410L的初步數據;研究結果包括沒有與藥物相關的嚴重不良事件、病變生長減少、視網膜組織保存、對低亮度視力功能性視覺測量的積極影響

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論